Editorial: Are implanted defibrillators effective therapy in the elderly? Asked, not answered

Circulation: Heart Failure

Volumn 3, Issue 1, 2010, Pages 4-6

  Havranek, Edward P ^a   Peterson, Pamela N ^a  

^a DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

Defibrillators; Elderly; Implantable

Indexed keywords

AGED; CLINICAL TRIAL; DEFIBRILLATOR; EDITORIAL; FUNDING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEART FAILURE; HUMAN; INFORMATION DISSEMINATION; INFORMATION STORAGE; MEDICAL INFORMATION; MORTALITY; PRIMARY PREVENTION; PRIORITY JOURNAL; RESEARCH; NOTE;

AGED; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HUMANS;

EID: 76549106371     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.109.931204     Document Type: Editorial

References (14)

1. Dhruva SS, Redberg RF. Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions. Arch Intern Med. 2008;168:136-140.
2. Pitt B, Zannad F, Remme WJ, Cody RJ, Castaigne A, Perez A, Palensky J, Wittes J; the Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341:709-717.
3. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA. Rates of hyperkalemia after publication of the randomized aldactone evaluation study. N Engl J Med. 2004;351:543-551.
4. Masoudi FA, Gross CP, Wang Y, Rathore SS, Havranek EP, Foody JM, Krumholz HM. Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001. Circulation. 2005;112:39-47.
5. http://www.hta.hca.wa.gov/stent.html. Accessed December 7, 2009.
6. Ezekowitz JA, Rowe BH, Dryden DM, Hooton N, Vandermeer B, Spooner C, McAlister FA. Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med. 2007;147:251-262.
7. McClellan MB, Tunis SR. Medicare coverage of ICDs. N Engl J Med. 2005;352:222-224.
8. Hammill SC, Kremers MS, Stevenson LW, Kadish AH, Heidenreich PA, Lindsay BD, Mirro MJ, Radford MJ, Wang Y, Curtis JP, Lang CM, Harder JC, Brindis RG. Review of the registry's second year, data collected, and plans to add lead and pediatric ICD procedures. Heart Rhythm. 2008;5:1359-1363.
9. Peterson PN, Daugherty SL, Wang Y, Vidaillet HJ, Heidenreich PA, Curtis JP, Masoudi FA; National Cardiovascular Data Registry. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation. 2009;119:1078-1084.
10. Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch Intern Med. 2009;169:1500-1506.
11. Bardy GH, Lee KL, Mark DB, Poole JE, M. D., Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
12. Hernandez AF, Fonarow GC, Hammill BG, Al-Khatib SM, Yancy CW, O'Connor CM, Schulman KA, Peterson ED, Curtis LH. Clinical effectiveness of implantable cardioverter-defibrillators among Medicare beneficiaries with heart failure. Circ Heart Fail. 2010;3:7-13.
13. Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA. Sex differences in the use of implantable cardioverterdefibrillators for primary and secondary prevention of sudden cardiac death. J Am Med Assoc. 2007;298:1517-1524.
14. Havranek EP, Simon TA, L'Italien G, Smitten A, Hauber AB, Chen R, Lapuerta P. The relationship between health perception and utility in heart failure patients in a clinical trial: results from an OVERTURE substudy. J Card Fail. 2004;10:339-343.